In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J first-quarter results

This article was originally published in The Rose Sheet

Executive Summary

The strong performance of skin-care lines Aveeno and Clean & Clear helped drive worldwide consumer sales up 48.5% to $3.5 bil. for the first quarter 2007, company announces April 17. J&J's combined consumer business - which includes skin care, baby and kids care, oral care, OTCs and nutritionals and women's health - increased 41.7% domestically to $1.6 bil. and 54.9% internationally to $1.9 bil. for the quarter, firm says. In the U.S., skin-care sales rose 13% to $357 mil., baby and kids care increased 5% to $109 mil., and oral care booked $203 mil. in revenue. J&J acquired Pfizer Consumer Healthcare in December 2006 (1"The Rose Sheet" Jan. 1, 2007, In Brief)...



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts